Pages that link to "Q40295940"

The following pages link to Biomarkers to assess the utility of potential reduced exposure tobacco products. (Q40295940):

Displaying 46 items.

• DNA damage response induced by tobacco smoke in normal human bronchial epithelial and A549 pulmonary adenocarcinoma cells assessed by laser scanning cytometry (Q28393323) (← links)
• PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk (Q28754477) (← links)
• Biomarkers of Tobacco Exposure: Summary of an FDA-sponsored Public Workshop (Q29248704) (← links)
• Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS (Q30536390) (← links)
• Evaluating the relationship between biomarkers of potential harm and biomarkers of tobacco exposure among current, past, and nonsmokers: data from the National Health and Nutrition Examination Survey 2007-2012. (Q31109084) (← links)
• Sociodemographic characteristics and diabetes predict invalid self-reported non-smoking in a population-based study of U.S. adults (Q33277968) (← links)
• Clinical trials methods for evaluation of potential reduced exposure products (Q33562506) (← links)
• Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention (Q33936367) (← links)
• Public education about the relative harm of tobacco products: an intervention for tobacco control professionals (Q33990091) (← links)
• Lung cancer in never smokers: molecular profiles and therapeutic implications (Q34177155) (← links)
• Developing the science base for reducing tobacco harm (Q34462613) (← links)
• A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation. (Q34558199) (← links)
• Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act (Q35624461) (← links)
• Tobacco and nicotine product testing (Q35624469) (← links)
• Study of cardiovascular disease biomarkers among tobacco consumers. Part 3: evaluation and comparison with the US National Health and Nutrition Examination Survey (Q35834310) (← links)
• Study of cardiovascular disease biomarkers among tobacco consumers, part 1: biomarkers of exposure (Q35834322) (← links)
• Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies (Q35854156) (← links)
• A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers (Q36441730) (← links)
• Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 3. Biomarkers of biological effect (Q36482329) (← links)
• Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure (Q36482371) (← links)
• Nicotine reduction: strategic research plan (Q36823218) (← links)
• Smoking and lung cancer: future research directions (Q36895457) (← links)
• Progress and challenges in selected areas of tobacco carcinogenesis (Q36916827) (← links)
• The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US (Q37024750) (← links)
• Monitoring the tobacco use epidemic II: The agent: Current and emerging tobacco products (Q37155822) (← links)
• Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers (Q37246043) (← links)
• Determination of tobacco specific hemoglobin adducts in smoking mothers and new born babies by mass spectrometry. (Q37280992) (← links)
• Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. (Q37461696) (← links)
• Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco (Q37467562) (← links)
• Environmental factors in causing human cancers: emphasis on tumorigenesis. (Q38012014) (← links)
• Changes in levels of biomarkers of exposure and biological effect in a controlled study of smokers switched from conventional cigarettes to reduced-toxicant-prototype cigarettes (Q40957564) (← links)
• A longitudinal study of smokers' exposure to cigarette smoke and the effects of spontaneous product switching (Q41207912) (← links)
• Cotinine concentration in serum correlates with tobacco smoke-induced emphysema in mice. (Q41891871) (← links)
• Evaluation of potential breath biomarkers for active smoking: assessment of smoking habits. (Q43148702) (← links)
• A cross-sectional investigation of biomarkers of risk after a decade of smoking. (Q43255980) (← links)
• Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes (Q44550667) (← links)
• Consortium on Methods Evaluating Tobacco: Research Tools to Inform FDA Regulation of Snus. (Q45070774) (← links)
• Cardiovascular biomarkers in groups of established smokers after a decade of smoking (Q46143110) (← links)
• A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro Lights or Marlboro Ultra Lights cigarettes (Q46530678) (← links)
• Smoking intensity before and after introduction of the public place smoking ban in Scotland (Q47399538) (← links)
• Day-to-Day Variability in Self-Reported Cigarettes Per Day. (Q47941731) (← links)
• Cognitive Effects of Nicotine: Recent Progress (Q48609200) (← links)
• Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 7: A one-month, randomized, ambulatory, controlled clinical study in Poland (Q50504186) (← links)
• Reference change values in concentrations of urinary and salivary biomarkers of exposure and mouth level exposure in individuals participating in an ambulatory smoking study. (Q53608869) (← links)
• Estimation and correlation of cigarette smoke exposure in Canadian smokers as determined by filter analysis and biomarkers of exposure (Q85179349) (← links)
• Electronic Cigarettes and the Lung Proteome (Q91177535) (← links)